KASID
Articles
- Page Path
- HOME > Intest Res > Volume 11(4); 2013 > Article
- Selected Summary The Efficacy of Vedolizumab, an α4β7 Integrin Antibody, in Crohn's Disease and Ulcerative Colitis
- Eun Sun Kim
-
[Epub ahead of print]
DOI: https://doi.org/10.5217/ir.2013.11.4.325
Published online: October 30, 2013
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Institute of Digestive Disease and Nutrition, Korea University College of Medicine, Seoul, Korea
- 2,252 Views
- 16 Download
- 0 Crossref
- 0 Scopus
Abstract
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis (N Engl J Med 2013;369:699-710) Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease (N Engl J Med 2013;369:711-721)
Cite
